Valtrex (valacyclovir) is generally considered safe to take while breastfeeding. Only very small amounts of the drug’s active form reach breast milk, and multiple clinical trials have found no adverse effects in breastfed infants whose mothers were taking standard doses. Both the NHS Specialist Pharmacy Service and MotherToBaby, a leading U.S. teratology resource, support its use during lactation.
How Much Reaches Your Baby
Valacyclovir is a prodrug, meaning your body rapidly converts it into acyclovir, its active component. Unchanged valacyclovir has never been detected in breast milk, maternal blood, or infant urine. What does appear in milk is acyclovir, and the amounts are small.
According to FDA labeling data from a study of five breastfeeding women taking 500 mg twice daily, the estimated infant dose through breast milk was approximately 0.6 mg/kg/day. That’s roughly 2% of the therapeutic dose used to treat newborns who actually have herpes infections (30 mg/kg/day). A larger randomized trial by Drake et al. found a similar figure of about 0.39 mg/kg/day, which works out to around 1% of the standard pediatric treatment dose.
To put this in longer-term perspective: a baby nursing for an entire year from a mother on 500 mg twice daily would absorb a cumulative total of roughly 717 mg of acyclovir. That’s 79% less than what a newborn receives during a standard 14- to 21-day course of intravenous herpes treatment. The gap between what your baby gets through milk and what would be considered a therapeutic dose is wide.
There’s another built-in safety margin. Acyclovir has poor oral bioavailability, meaning even the small amount an infant swallows in breast milk is only partially absorbed through the gut. This further limits how much active drug actually enters the baby’s bloodstream.
What Clinical Trials Have Found
A 2024 systematic review published in the journal Viruses examined all available evidence on antiviral use during breastfeeding. Across multiple studies, no significant adverse effects were reported in mothers or their breastfed infants taking valacyclovir. The review concluded that valacyclovir is “generally safe for breastfeeding mothers, with minimal infant exposure and low risk of adverse effects.”
One of the larger trials, a randomized, double-blind, placebo-controlled study by Drake et al., followed mothers taking 500 mg twice daily during late pregnancy and early breastfeeding. Not only were no harmful effects seen in infants, but babies in the valacyclovir group actually had lower rates of eczema and oral thrush compared to those in the placebo group. Other case reports have documented safe breastfeeding even at higher acyclovir doses, including intravenous treatment for eczema herpeticum, with infant acyclovir exposure still well below concerning levels.
What to Watch For in Your Baby
Although side effects in breastfed infants are not expected, the NHS Specialist Pharmacy Service recommends monitoring as a precaution. Keep an eye out for unusual drowsiness, irritability, skin rashes, vomiting, or diarrhea. These would be unusual, and none of these symptoms were reported in clinical trials, but they represent the known side effect profile of acyclovir in general.
If You Use Topical Acyclovir on Your Breasts
If you’re applying acyclovir cream or ointment directly to your breast or nipple area, clean the skin thoroughly before nursing. The concern here isn’t systemic drug transfer through milk but rather your baby coming into direct contact with the medication on your skin. For oral valacyclovir tablets, no special timing around feedings is necessary. There’s no evidence that pumping and dumping offers any benefit, since the drug levels in milk are already so low.
Active Herpes Lesions and Breastfeeding
The medication itself is safe, but active herpes sores on or near the nipple are a separate concern. Herpes simplex can be transmitted through direct skin-to-skin contact with an open lesion, and neonatal herpes is a serious infection. If you have active blisters on the breast you’re nursing from, avoid feeding from that side until lesions have fully healed. You can continue nursing from the unaffected breast and pump from the affected side to maintain supply, discarding that milk. Lesions elsewhere on the body that your baby won’t contact during feeding do not require any changes to breastfeeding.
Acyclovir is routinely given directly to newborns who need it, which provides additional reassurance that the trace amounts transferred through breast milk are well within safe limits for infants.